Search results for "Cryptorchidism"

showing 6 items of 6 documents

Parental occupational exposure to endocrine disrupting chemicals and male genital malformations: a study in the Danish National Birth Cohort study

2011

Abstract Background Sex hormones closely regulate development of the male genital organs during fetal life. The hypothesis that xenobiotics may disrupt endogenous hormonal signalling has received considerable scientific attention, but human evidence is scarce. Objectives We analyse occurrence of hypospadias and cryptorchidism according to maternal and paternal occupational exposure to possible endocrine disrupting chemicals. Methods We conducted a follow-up study of 45,341 male singleton deliveries in the Danish National Birth Cohort during 1997-2009. Information on work during pregnancy was obtained by telephone interviews around gestational week 16. Parents' job titles were classified acc…

Malemedicine.medical_specialtyDenmarkHealth Toxicology and MutagenesisJob-exposure matrixEndocrine DisruptorsCohort StudiesInterviews as Topiclcsh:RC963-969PregnancyOccupational ExposureCryptorchidismMedicineHumansSex organCumulative incidenceGynecologyPregnancyHypospadiasbusiness.industryObstetricsResearchlcsh:Public aspects of medicineInfant NewbornPublic Health Environmental and Occupational HealthInfantlcsh:RA1-1270medicine.diseasePaternal ExposureHypospadiasMaternal ExposureChild PreschoolPrenatal Exposure Delayed Effectslcsh:Industrial medicine. Industrial hygieneGestationFemalebusinessCohort studyFollow-Up Studies
researchProduct

SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Down’s syndrome subjects with undescended testes

2009

Down’s syndrome (DS) is one of the most common numer- ical chromosomal aberrations, usually caused by trisomy of chromosome 21, and is frequently complicated with congen- ital heart defects, duodenal obs truction and other conditions including undescended testis (UDT) (Fonkalsrud 1970). The incidence of undescended testes in DS was reported to be 6.52% (Chew and Hutson 2004) while the incidence of UDT in the first year is approximately 0.2%–0.8% in the nor- mal population (Benson et al . 1991; Ichiyanagi et al . 1998). Rapley et al . (2000) provided evidence for a testicular germ- cell tumours (TGCT) predisposition locus at Xq27; the au- thors obtained an hlod score of 4.7 from families wit…

Malemedicine.medical_specialtyAdolescentPopulationGene DosageBiologyGene dosageYoung AdultSettore MED/38 - Pediatria Generale E SpecialisticaInternal medicineCryptorchidismGeneticsmedicineHumansChildeducationGynecologyeducation.field_of_studyS syndromeIncidence (epidemiology)Genetic VariationNuclear Proteinsmedicine.diseaseNeoplasm ProteinsSPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Down's syndrome subjects with undescended testes.EndocrinologyChild PreschoolDown SyndromeTrisomyJournal of Genetics
researchProduct

Laparoscopy for Abdominal Testes: Nationwide Analysis of German Routine Data

2021

Introduction: Laparoscopy has been used for the evaluation of impalpable testes for more than 30 years. However, its use for intra-abdominal testes has never been evaluated in a population-based ap...

Malemedicine.medical_specialtyAdolescentmedicine.medical_treatmentPopulationPopulation basedMedical RecordsGerman03 medical and health sciences0302 clinical medicineGermanyCryptorchidismHumansMedicineOrchiopexyChildeducationLaparoscopyeducation.field_of_studymedicine.diagnostic_testbusiness.industryGeneral surgeryHealth services researchInfantlanguage.human_languageSurgeryTreatment OutcomeChild PreschoolOrchiopexy030220 oncology & carcinogenesislanguageLaparoscopy030211 gastroenterology & hepatologySurgerybusinessJournal of Laparoendoscopic & Advanced Surgical Techniques
researchProduct

Treatment of cryptorchidism with a potent analog of gonadotropin-releasing hormone.

1978

Pernasal therapy of cryptorchidism with D-Leu6-des-Gly10-gonadotropin-releasing hormone ethylamide (D-Leu6-des-Gly10-GnRH-EA), a potent, long-acting GnRH analog, was attempted. Eleven prepubertal cryptorchid boys received between 25 microgram once daily and 25 to 50 microgram twice daily for 5 to 12 weeks. Complete testicular descent was achieved in 4 of the 11 boys. GnRH tests (1.5 microgram/kg intravenously), conducted in six boys before treatment, after 4 weeks of treatment, and in 2 boys 3 months after treatment, did not reveal changes in gonadotropin secretion indicative of precocious puberty or of decreased hypophyseal sensitivity to GnRH. Antibodies to the GnRH analog or to GnRH coul…

Maleendocrine systemmedicine.medical_specialtyTime FactorsGonadotropin-releasing hormoneInternal medicineCryptorchidismMedicinePrecocious pubertyHumansChildbusiness.industryObstetrics and GynecologyInfantGnRH AnalogLuteinizing Hormonemedicine.diseaseGonadotropin secretionEndocrinologyReproductive MedicineChild PreschoolAntibody FormationOnce dailyFollicle Stimulating HormonebusinessPituitary Hormone-Releasing Hormoneshormones hormone substitutes and hormone antagonistsAfter treatmentGonadotropinsHormoneFertility and sterility
researchProduct

HeterozygousFGF8mutations in patients presenting cryptorchidism and multiple VATER/VACTERL features without limb anomalies

2014

Background The acronym VATER/VACTERL association describes the combination of at least three of the following cardinal features: vertebral defects, anorectal malformations, cardiac defects, tracheoesophageal fistula with or without esophageal atresia, renal malformations, and limb defects. Although fibroblast growth factor-8 (FGF8) mutations have mainly found in patients with Kallmann syndrome, mice with a hypomorphic Fgf8 allele or complete gene invalidation display, aside from gonadotropin-releasing hormone deficiency, parts or even the entire spectrum of human VATER/VACTERL association. Methods We performed FGF8 gene analysis in 49 patients with VATER/VACTERL association and 27 patients …

Delayed pubertyEmbryologymedicine.medical_specialtyKallmann syndromeTracheoesophageal fistulaGeneral MedicineBiologyUnilateral cryptorchidismmedicine.diseaseVACTERL associationGastroenterologyHypergonadotropic hypogonadismEndocrinologyInternal medicineAtresiaPediatrics Perinatology and Child HealthGene duplicationmedicinemedicine.symptomDevelopmental BiologyBirth Defects Research Part A: Clinical and Molecular Teratology
researchProduct

Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines.

2016

Summary Context Undescended testis is the most common endocrinological disease in the male newborn period. Incidence varies between 1.0% and 4.6% in full-term neonates, with rates as high as 45% in preterm neonates. Failure or delay of treatment can result in reduced fertility and/or increased testicular cancer risk in adulthood. Objective To provide recommendations for the diagnosis and treatment of boys with undescended testes which reduce the risk of impaired fertility and testicular cancer in adulthood. Evidence acquisition Embase and Pubmed were searched for all relevant publications, from 1990 to 2015 limited to English language. Data were narratively synthesized in light of methodolo…

Malemedicine.medical_specialtyBOYSNONPALPABLE TESTISUrologymedia_common.quotation_subjectmedicine.medical_treatment030232 urology & nephrologyMEDLINEUrologyFertilityContext (language use)CRYPTORCHID TESTISCHILDRENDiseaseOrchidopexy03 medical and health sciences0302 clinical medicineHUMAN CHORIONIC-GONADOTROPINTesticular cancerTESTICULAR DESCENT030225 pediatricsCryptorchidismmedicineHumansOrchiopexyTesticular cancermedia_commonGONADOTROPIN-RELEASING-HORMONEFERTILITY INDEXbusiness.industryIncidence (epidemiology)Infantmedicine.diseaseFertilityUndescended testisPediatrics Perinatology and Child HealthSURGICAL-MANAGEMENTHormonal therapybusinessORCHIOPEXYJournal of pediatric urology
researchProduct